The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects
by
Stough C, Lloyd J, Clarke J, Downey LA,
Hutchison CW, Rodgers T, Nathan PJ.
Neuropsychology Laboratory,
School of Biophysical Science and Electrical Engineering,
Victoria, Australia.
Psychopharmacology (Berl). 2001 Aug;156(4):481-4.

ABSTRACT

RATIONALE: Extracts of Bacopa monniera have been reported to exert cognitive enhancing effects in animals. However, the effects on human cognition are inconclusive. OBJECTIVE: The current study examined the chronic effects of an extract of B. monniera (Keenmind) on cognitive function in healthy human subjects. METHODS: The study was a double-blind placebo-controlled independent-group design in which subjects were randomly allocated to one of two treatment conditions, B. monniera (300 mg) or placebo. Neuropsychological testing was conducted pre-(baseline) and at 5 and 12 weeks post drug administration. RESULTS: B. monniera significantly improved speed of visual information processing measured by the IT task, learning rate and memory consolidation measured by the AVLT (P<0.05), and state anxiety (P<0.001) compared to placebo, with maximal effects evident after 12 weeks. CONCLUSIONS: These findings suggest that B. monniera may improve higher order cognitive processes that are critically dependent on the input of information from our environment such as learning and memory.

Bacopa monniera
The memory switch?
Dumb-drug euphoria
Growing new brain cells
Bacopa monniera and bacosides
Bacopa monniera and human memory
Bacopa monniera: double-blind placebo-controlled trial

Refs
and further reading

HOME
HedWeb
Nootropics
cocaine.wiki
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family